Related Experiment Video
Updated: Jun 4, 2026
10:57
NF-κB-dependent Luciferase Activation and Quantification of Gene Expression in Salmonella Infected Tissue Culture Cells
Published on: January 12, 2020
NF-κB activation in organs from STZ-treated rats
Marius Locke1, Jocelyn Anderson
1Faculty of Physical Education and Health, University of Toronto, 55 Harbord Street, Toronto, ON M5S 2W6, Canada. marius.locke@utorondo.ca
Summary
Diabetes alters nuclear factor kappa B (NF-κB) activation in rodent tissues. The p65 subunit increased in diabetic hearts, suggesting specific NF-κB changes in disease.
Area of Science:
- Molecular Biology
- Immunology
- Endocrinology
Background:
- Nuclear factor kappa B (NF-κB) is a key transcription factor involved in inflammation and disease pathogenesis.
- Specific NF-κB subunits and their activation patterns are crucial for understanding disease mechanisms.
Purpose of the Study:
- To investigate the impact of a 1-month diabetic state on NF-κB activation, subunit composition, and related protein content in rodent organs.
- To determine tissue-specific alterations in NF-κB signaling pathways during diabetes.
Main Methods:
- Diabetes was induced in rats using streptozotocin (STZ).
- NF-κB activation and subunit composition were analyzed using electrophoretic mobility shift assay (EMSA).
- Protein content of NF-κB subunits p50 and p65 was quantified via Western blotting.
Main Results:
- Constitutive NF-κB activation decreased in the liver but remained unchanged in the kidney, spleen, and heart of diabetic rats.
- The p50 subunit was predominant in NF-κB complexes across all tissues and groups.
- The p65 subunit was detected in NF-κB complexes from diabetic hearts, and its content increased specifically in diabetic hearts.
Conclusions:
- A diabetic state induces distinct changes in NF-κB subunit composition within specific tissues.
- These findings highlight the complex role of NF-κB signaling in diabetic pathophysiology.
- Tissue-specific modulation of NF-κB subunits may offer insights into disease development and potential therapeutic targets.
Related Concept Videos
02:26NF-κB-dependent Signaling Pathway
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
02:26NF-kB-dependent Signaling Pathway
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...